{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:09Z","timestamp":1786119489878,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/iae.0b013e3181dc58bf","type":"journal-article","created":{"date-parts":[[2010,4,5]],"date-time":"2010-04-05T13:46:37Z","timestamp":1270475197000},"page":"S51-S58","source":"Crossref","is-referenced-by-count":35,"title":["EPIRETINAL MEMBRANES INDICATE A SEVERE PHENOTYPE OF NEUROFIBROMATOSIS TYPE 2"],"prefix":"10.1097","volume":"30","author":[{"given":"ROBERT A.","family":"SISK","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AUDINA M.","family":"BERROCAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AMY C.","family":"SCHEFLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SANDER R.","family":"DUBOVY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MISLEN S.","family":"BAUER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tcb.2007.03.006","article-title":"Shedding light on Merlin's wizardry.","volume":"17","author":"Okada","year":"2007","journal-title":"Trends Cell Biol"},{"key":"R2-11-20210130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jmg.29.12.841","article-title":"A genetic study of type 2 neurofibromatosis in the United Kingdom. I: Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity.","volume":"29","author":"Evans","year":"1992","journal-title":"J Med Genet"},{"key":"R3-11-20210130","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1212\/01.WNL.0000035638.74084.F4","article-title":"Evaluation of clinical diagnostic criteria for neurofibromatosis 2.","volume":"59","author":"Baser","year":"2006","journal-title":"Neurology"},{"key":"R4-11-20210130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jmg.40.2.109","article-title":"Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.","volume":"40","author":"Kluwe","year":"2003","journal-title":"J Med Genet"},{"key":"R5-11-20210130","first-page":"529","article-title":"Germline mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.","volume":"59","author":"Parry","year":"1996","journal-title":"Am J Hum Genet"},{"key":"R6-11-20210130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.1320520411","article-title":"Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.","volume":"52","author":"Parry","year":"1994","journal-title":"Am J Med Genet"},{"key":"R7-11-20210130","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0161-6420(92)31789-0","article-title":"Ocular findings associated with neurofibromatosis type II.","volume":"99","author":"Kaye","year":"1992","journal-title":"Ophthalmology"},{"key":"R8-11-20210130","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/adc.81.6.496","article-title":"Paediatric presentation of type 2 neurofibromatosis.","volume":"81","author":"Evans","year":"1999","journal-title":"Arch Dis Child"},{"key":"R9-11-20210130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/422700","article-title":"Genotype\u2013phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.","volume":"75","author":"Baser","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R10-11-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3928\/15428877-20080101-13","article-title":"Optical coherence tomography of epiretinal membranes in neurofibromatosis 2.","volume":"39","author":"Schefler","year":"2008","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R11-11-20210130","first-page":"245","article-title":"Retinal changes associated with neurofibromatosis 2.","volume":"93","author":"Meyers","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R12-11-20210130","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ajo.2005.12.042","article-title":"Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2.","volume":"141","author":"Bosch","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R13-11-20210130","first-page":"331","article-title":"Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease.","volume":"59","author":"Ruttledge","year":"1996","journal-title":"Am J Hum Genet"},{"key":"R14-11-20210130","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/342716","article-title":"Predictors of the risk of mortality in neurofibromatosis 2.","volume":"71","author":"Baser","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R15-11-20210130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmg.35.6.450","article-title":"Genotype\/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.","volume":"35","author":"Evans","year":"1998","journal-title":"J Med Genet"},{"key":"R16-11-20210130","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s004390050255","article-title":"Identification of NF2 germ-line mutations and comparison with NF2 phenotypes.","volume":"98","author":"Kluwe","year":"1996","journal-title":"Hum Genet"},{"key":"R17-11-20210130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archopht.125.3.389","article-title":"Ocular pathologic findings of neurofibromatosis type 2.","volume":"125","author":"McLaughlin","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R18-11-20210130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3341\/kjo.1995.9.2.84","article-title":"Ultrastructural change of the M\u00fcller cell in the culture of sensory retina.","volume":"9","author":"Song","year":"1995","journal-title":"Korean J Ophthalmol"},{"key":"R19-11-20210130","first-page":"101","article-title":"Congenital retino-pigment epithelial malformation, previously described as hamartomas.","volume":"20","author":"Laqua","year":"1979","journal-title":"Mod Probl Ophthalmol"},{"key":"R20-11-20210130","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1001\/archopht.123.12.1746","article-title":"Optical coherence tomography findings of combined hamartoma of the retina and retinal pigment epithelium in 11 patients.","volume":"123","author":"Shields","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R21-11-20210130","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0002-9394(14)73372-0","article-title":"Clinicopathologic results of vitreous surgery for epiretinal membranes in patients with combined retinal and retinal pigment epithelial hamartomas.","volume":"100","author":"MacDonald","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"R22-11-20210130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-4835(05)80043-0","article-title":"Effects of M\u00fcller cell disruption on mouse photoreceptor cell development.","volume":"61","author":"Rich","year":"1995","journal-title":"Exp Eye Res"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-201004001-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:21:03Z","timestamp":1786040463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201004001-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181dc58bf","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}